DIAJARD L 5/10MG TAB

DIAJARD L 5/10MG is a combination tablet containing Linagliptin 5mg and Empagliflozin 10mg. This dual-action medication is designed to help manage type 2 diabetes by improving blood sugar control through two complementary mechanisms. Linagliptin works by increasing insulin secretion, while Empagliflozin helps the kidneys eliminate excess glucose through urine. Together, they provide comprehensive glycemic management for patients requiring combination therapy. Suitable for adults with type 2 diabetes when diet and exercise alone are insufficient. Always use as directed by your healthcare provider.